Lineage Cell Therapeutics, Inc. (LCTX)

1.735 +0.10 (+5.79%) USD  |  NYAM  |  Apr 17, 15:26
More

Lineage Cell Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for LCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
The Cooper Cos., Inc. Upgrade
Pacira Biosciences, Inc. Upgrade
OptimizeRx Corp. Upgrade
Nutex Health, Inc. Upgrade
Prime Medicine, Inc. Upgrade